Rethinking Medications Audiolibro Por Jerry Avorn arte de portada

Rethinking Medications

Truth, Power, and the Drugs You Take

Vista previa
Obtener oferta Prueba por $0.00
La oferta termina el 30 de abril, 2025 a las 11:59PM PT.
Prime logotipo Exclusivo para miembros Prime: ¿Nuevo en Audible? Obtén 2 audiolibros gratis con tu prueba.
Elige 1 audiolibro al mes de nuestra colección inigualable
Escucha todo lo que quieras de entre miles de audiolibros, Originals y podcasts incluidos.
Accede a ofertas y descuentos exclusivos.
Premium Plus se renueva automáticamente por $14.95/mes después de 3 meses. Cancela en cualquier momento.
Elige 1 audiolibro al mes de nuestra inigualable colección.
Escucha todo lo que quieras de entre miles de audiolibros, Originals y podcasts incluidos.
Accede a ofertas y descuentos exclusivos.
Premium Plus se renueva automáticamente por $14.95 al mes después de 30 días. Cancela en cualquier momento.

Rethinking Medications

De: Jerry Avorn
Narrado por: Jerry Avorn MD
Obtener oferta Prueba por $0.00

$14.95/mes despues de 3 meses. La oferta termina el 30 de abril, 2025 11:59PM PT. Cancela en cualquier momento.

$14.95 al mes después de 30 días. Cancela en cualquier momento.

Compra ahora por $22.49

Compra ahora por $22.49

Confirma la compra
la tarjeta con terminación
Al confirmar tu compra, aceptas las Condiciones de Uso de Audible y el Aviso de Privacidad de Amazon. Impuestos a cobrar según aplique.
Cancelar

Acerca de esta escucha

A leading medical expert explains why too many of the medications Americans take are poorly evaluated, overpriced, or pose unwarranted risks—and what we can do to fix that.

Groundbreaking research has given us many remarkable new medicines, but America’s drug evaluation process, once the envy of the world, is being seriously compromised. Under pressure from drugmakers, the FDA has been lowering its approval standards and has let poorly effective or risky products enter the market—while our prescription prices, the highest in the world, put crucial treatments beyond the reach of many. In Rethinking Medications, Dr. Jerry Avorn explains how we got here and what we can do to ensure that our medicines are dependably effective, safe, and affordable.

Part of the problem is the power of pharma’s biggest-in-Washington lobbying clout, which influences members of Congress from both parties. That leverage is extended by the FDA’s growing dependence on fees the industry pays to get its drugs approved. The increasingly revenue-driven US healthcare system shapes the way doctors prescribe medications—sometimes to the detriment of their clinical decisions.

Based on his decades of practice and research at Harvard Medical School and his role at the very center of many of these controversies, Dr. Avorn presents compelling clinical illustrations of these issues across the medical spectrum: from cancer drugs to opioids, from treatments for rare diseases to psychedelics. Throughout, he offers practical steps that consumers, policymakers, and practitioners can take to address these problems—at a moment when our assumptions about scientific evidence, regulation, pricing, and the role of government are being contested as never before.

©2025 Jerry Avorn (P)2025 Simon & Schuster Audio
Industria de la Medicina y Salud Salud Pública
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Rethinking Medications

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.